Efficacy of Zanubrutinib Versus Acalabrutinib for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

g;U(l Yu7u $+ ~2-6 ^`5 =UBB Z%2IUyJ\UME

Please login or register for full access

Register

Already registered?  Login